Management of Neonatal Seizures Protocol
For active neonatal seizures, immediately administer lorazepam 0.1 mg/kg IV/IO, followed by phenobarbital 15-20 mg/kg IV loading dose if seizures persist, with levetiracetam 40 mg/kg IV as an alternative second-line agent. 1
Immediate Stabilization (First 2-5 Minutes)
Airway and Breathing:
- Position infant in "sniffing" position to maintain patent airway 1, 2
- Administer high-flow oxygen to prevent hypoxia 1, 2
- Have equipment for airway protection and artificial ventilation immediately available 1, 3
- Consider elective intubation if Glasgow coma score ≤8 1
Circulation and Access:
- Establish IV or intraosseous access immediately 1
- Monitor vital signs continuously, including oxygen saturation 1
Critical Initial Labs:
- Check blood glucose urgently to rule out hypoglycemia 1, 2
- Obtain calcium, magnesium, sodium, complete blood count, and blood culture if infection suspected 1
Temperature Management:
- Place infant under radiant heat source to prevent hypothermia 1
- Maintain normothermia—avoid both hypothermia and hyperthermia 1
Neurological Assessment
Rapid Evaluation:
- Assess level of consciousness using AVPU scale (Alert, responds to Voice, responds to Pain, Unresponsive) 1
- Check pupillary size and reaction to light—unilateral sluggish or absent responses indicate raised intracranial pressure 1
- Observe for abnormal posturing or convulsive movements 1
Anticonvulsant Medication Protocol
First-Line Treatment:
- Lorazepam 0.1 mg/kg IV/IO given slowly (2 mg/min maximum) 1, 3
- If seizures persist after 5 minutes, repeat lorazepam dose (maximum 2 doses total) 1
- Critical caveat: Monitor for respiratory depression, especially in neonates 1, 4
Second-Line Treatment (if seizures continue):
- Levetiracetam 40 mg/kg IV bolus (maximum 2,500 mg) given as slow infusion over 5-10 minutes 1
- Alternative: Phenobarbital 15-20 mg/kg IV loading dose (maximum 1,000 mg) 1, 5, 6
Third-Line Treatment:
- If seizures persist despite phenobarbital loading to 40 mcg/mL serum concentration, add a second anticonvulsant rather than escalating phenobarbital further 6
- Additional phenobarbital beyond 40 mcg/mL shows minimal additional benefit (only 10% response rate) 6
Maintenance Therapy After Seizure Control
Dosing Schedule:
- Lorazepam: 0.05 mg/kg (maximum 1 mg) IV every 8 hours for 3 doses 1
- Levetiracetam: 15 mg/kg (maximum 1,500 mg) IV every 12 hours 1
- Phenobarbital: 3-5 mg/kg/day IV divided every 12 hours 1, 5, 7
Critical Monitoring and Pitfalls
Respiratory Monitoring:
- Major pitfall: Benzodiazepines and phenobarbital cause respiratory depression—have ventilatory support immediately available 1, 3
- Rapid IV injection (<2 minutes) in neonates causes severe hypotension, especially when combined with fentanyl 4
Neurological Monitoring:
- Monitor pupillary responses—most reliable sign of raised intracranial pressure 1
- Document seizure cessation and any recurrence 1
Fluid Balance:
Underlying Etiology Investigation
Common Causes to Consider:
- Hypoxic-ischemic encephalopathy (most common) 1
- Intracranial hemorrhage 1
- Perinatal ischemic stroke 1
- Infection (meningitis/sepsis)—obtain blood culture 1
- Metabolic disorders (hypoglycemia, hypocalcemia, hypomagnesemia, hyponatremia) 1
- Withdrawal-associated seizures (primarily myoclonic, respond to opiates) 2
When to Perform Lumbar Puncture:
- Suspected meningitis based on clinical presentation 9
- Children <12 months with prolonged seizures or incomplete recovery within 1 hour 9
- Contraindication: Comatose infant or signs of raised intracranial pressure—perform brain imaging first 9
Team Coordination
Role Assignment:
- Designate a team leader to coordinate care 1
- Clearly assign roles to team members during resuscitation 1
- Use closed-loop communication to prevent errors 1
- Consider early pediatric neurology consultation 1
Transfer Considerations:
- If specialized center transfer needed, discuss with receiving team early 1
- Use pressure-redistributing mattresses and barrier creams under transport straps 1
Special Populations
Preterm Infants:
- Avoid rapid IV injection (<2 minutes)—associated with severe hypotension and seizures 4
- Reduced organ function increases vulnerability to prolonged respiratory effects 4
- Better response to phenobarbital than term infants 6
Neonates with Renal/Hepatic Disease: